Managers

Quark Venture, GF Securities unveil $500 mln health sciences fund

Canadian venture capital firm Quark Venture and GF Securities Co Ltd, a Chinese investment bank, have launched a US$500 million health sciences fund. The fund, which held an initial close of US$100 million, will invest in global biotechnology and health sciences companies. Karimah Es Sabar, recently named Quark's CEO and partner, said it will focus on building a portfolio of "game-changing innovations in drug development, medical devices, health IT and emerging convergent technologies." Quark earlier this month led the US$30 million financing of Vancouver's MSI Methylation Sciences Inc.

Quark Venture and GF Securities unveil $500 mln health sciences fund

Canadian venture firm Quark Venture Inc has teamed up with China-based investment bank GF Securities Company Limited to launch a $500 million venture fund. Based in Vancouver, British Columbia, the fund will focus on global biotech and health sciences companies.

Sinovation Ventures collects over $302 mln for third fund

Sinovation Ventures has raised over $302 million for its third fund, according to an SEC filing. The San Francisco-based early-stage venture firm focuses on Chinese and U.S. tech startups.

Portag3 Ventures launched to invest in fintech opportunities

Portag3 Ventures, a new Canadian venture capital fund focused on deal-making in the financial technology (fintech) industry, has closed at an undisclosed amount. The fund is an exclusive corporate partnership of financial affiliates of Montréal-based Power Corp (TSX: POW), including Power Financial Corp, IGM Financial Inc and Great-West Lifeco Inc. Adam Felesky, co-founder and former CEO of Horizons Exchange Traded Funds, has been appointed president of Portag3, and Paul Desmarais III, a vice-president of Power Corp, will serve as executive chairman. Portag3 will target investments in early-stage fintech opportunities in Canada.

Sofinnova closes on $650 mln 10th fund

Sofinnova Ventures has closed a $650 million 10th fund with an increase in capital and a goal to invest in more companies.

Sofinnova closes on $650 mln 10th fund, adds partner

DN Capital and the London-Berlin connection in the Brexit era

Navigating the cybersecurity doldrums in 2016 and beyond

Scenic Advisement, Nasdaq Private Market team up on secondary sales

Dashboard: Venture fundraising falls in September, as IPOs rise